Surveillance epidemiological: parvovirus B19 genotype 1
Vol. 67 No. 1 (2008), ORIGINAL ARTICLE
Vol. 67 No. 1 (2008)

Surveillance epidemiological: parvovirus B19 genotype 1

ORIGINAL ARTICLE
https://doi.org/10.53393/rial.2008.67.32793
Published 2008-01-01
Maria Isabel de Oliveira
Instituto Adolfo Lutz, Serviço de Virologia, São Paulo, SP
Ana Maria Sardinha Afonso
Instituto Adolfo Lutz, Divisão de Biologia Médica, Seção Vírus Produtores de Exantemas, São Paulo, SP
Cristina Adelaide Figueiredo
Instituto Adolfo Lutz, Serviço de Virologia, São Paulo, SP
Ana Lucia Frugis Yu
Ministério da Saúde, Centro de Vigilância Epidemiológica, DDTR, São Paulo, SP
Suely Pires Curti
Instituto Adolfo Lutz, Divisão de Biologia Médica, Seção Vírus Produtores de Exantemas, São Paulo, SP
PDF

Keywords

human parvovirus B19
molecular epidemiology
nucleotide sequence
erythrovirus
erythema infectiosum

How to Cite

1.
Oliveira MI de, Afonso AMS, Figueiredo CA, Yu ALF, Curti SP. Surveillance epidemiological: parvovirus B19 genotype 1. Rev Inst Adolfo Lutz [Internet]. 2008 Jan. 1 [cited 2024 Dec. 4];67(1):69-72. Available from: https://periodicos.saude.sp.gov.br/RIAL/article/view/32793
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Human parvovirus B19 was identified and characterized in sample collected from a patient who was infected in Japan, and the symptoms as fever and rash appeared after arriving to Brazil. The occurrence of virus infection was confirmed by both assays: Elisa parvovirus B19-specific IgM antibody detection and polymerase chain reaction (PCR). A fragment of NS1-VP1 region was directly submitted to nucleotide sequencing. Partial phylogenetic analysis of B19 sequences, including several sequences available in GenBank, indicated that the isolated HPV B19 corresponded to genotype 1.
https://doi.org/10.53393/rial.2008.67.32793
PDF

References

1. Siegl GR, Bates RC, Bern KI, Carter BJ, Kelly DC, Kurtak E, etal. Characteristics and taxonomy of Parvoviridae. Intervirology. 2005;23:61-71.

2. Chen YS, Chou PH, Li SN, Tsai WC, Lin KH, Tsai KB, Yen JH,Liu HW. Parvovirus B19 infection in patients with rheumatoidarthritis in Taiwan. Rheumatol. 2006 ;33:887-91.

3. Corcoran A, Doyle S. Advances in the biology, diagnosisand host-pathogen interacrions of parvovirus B19. JMedMicrobiol. 2004;53: 469-75.

4. Hemauer A., Poblotzki AV, Gigler A, Cassinotti P, Siegl G, WolfH, et al. Sequence variability among different parvovirus B19 isolates. J Gen Virol. 1996;77:1781-5.

5. Parsyan A, Szmaragd C, Allain JP, Candotti D. Identificationand genetic diversity of two human parvovirus B19 genotype3 subtypes. JGen Virol. 2007;88:428-31.

6. Servant A, Laperche S, Lallemand F, Marinho V, De SaintMaur G, Meritet JF, et al. Genetic diversity within humanerythroviruses: identification of three genotypes. J Virol.2002;76:9124-34.

7. Ekman A, Hokynar K, Kakkola L, Kantola K, Hedman L,Bondén H, Gessner M, Aberham C, Norja P, Miettinen S,Hedman K, SA¶derlund-Venermo M. Biological andimmunological relations among human parvovirus B19 genotypes 1 to 3. J Virol. 2007;81:6927-35.

8. Baylis SA, Fryer JF, Grabarczyk P. Effects of probe bindingmutations in an assay designed to detect parvovirus B19: implications for the quantitation of different virus genotypes. J Virol Methods. 2007;139:97-9.

9. Durigon EL, Erdman DD, Gary GW, Pallansch MA, Torok TT,Anderson LJ. Multiple primer pairs for polimerase chainreaction (PCR) amplification of human parvovirus B19 DNA.J Virol Methods. 1993;44:155-65.

10. Altschul S, Madden T, Schaffer A, Zhang OZ, Miller W, LipmanD.G. Blast and PSI-Blast. A new generation of protein tatabascscarch programs. Nucleic Acids Res. 1997; 25:3389-402.

11. Yaegashi N, Shiraishi H, Takeshita T, Nakamura M, Yajima A,Sugamura K. Propagation of human parvovirus B19 in primaryculture of erythroid lineage cells derived from fetal liverculture. J Gen Virol. 1989;63:2422-6.

12. Swofford DL. PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). In: Sinauer Associates 4thed. Sunderland: Massachusetts; 2003.

13. Posada D, Crandall KA. ModelTest: testing the model ofDNA substitution. Bioinformatic. 1998;14: 817-8.

14. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection.J Intern Med. 2006;260:285-304.

15. Saldanha J, Lelie N, Yu MW, Heath A. B19 Collaborative Study Group. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.Vox Sang.2002;82:24-31.

16. Cohen BJ, Gandhi J, Clewley JP. Genetic variants ofparvovirus B19 identified in the United Kingdom: implicationsfor diagnostic testing. J Clin Virol. 2006;36:152-5.

17. Us T, Ozune L, Kasifoglu N, Akgun Y. The investigation ofparvovirus B19 infection in patients with haematological disorders by using PCR and ELISA techniques. Braz J InfectDis. 2007;11:327-30.

18. Heegaard ED, Jensen IP, Christensen J. Novel PCR assay fordifferential detection and screening of erythrovirus B19 anderythrovirus V9. J Med. Virol. 2001;65:362-7.

19. Umene K, Nunoue T. The genome type of human parvovirusB19 strains isolated in Japan during 1981 differs from typesdetected in 1986 to 1987: a correlation between genome typeand prevalence. J Gen Virol. 1990;71:983-6.

20. Sanabani S, Neto WK, Pereira J, Sabino EC. Sequencevariability of human erythroviruses present in bone marrowof Brazilian patients with various parvovirus B19-relatedhematological symptoms. Clin Microbiol. 2006;44:604-6.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2008 Instituto Adolfo Lutz Journal

Downloads

Download data is not yet available.